WASHINGTON – House Republicans produced documents Wednesday that they said prove at least one company is illegally profiting from the study of human fetal tissue, but Democrats on the panel said there is no evidence that New Mexico organizations under scrutiny are profiting.
The Select Investigative Panel on Infant Lives convened its second hearing to examine the controversial issue of fetal tissue research, which triggered fierce congressional debate after a series of secret videos last summer appeared to show Planned Parenthood officials haggling over the price of fetal tissue.
Under federal law, abortion providers can’t sell fetal tissue, but they can transfer it for purposes of medical research. Abortion providers are permitted to recover the cost of processing and shipping the tissue, although those costs are not specified or capped by law.
The University of New Mexico Health Sciences Center, which has studied fetal tissue, and Southwestern Women’s Options, an Albuquerque abortion provider that has provided fetal specimens for research, have both been subpoenaed for documentation by the House special investigative committee.